Ken Griffin Meira G Tx Holdings PLC Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$3.88 - $5.23 $19,400 - $26,150	-5,000 Reduced 20.66%	19,200 $80,000
Q2 2024 Aug 14, 2024	BUY	$4.21 - $5.81 $87,989 - $121,428	20,900 Added 633.33%	24,200 $101,000
Q1 2024 May 15, 2024	BUY	$5.78 - $7.33 $2,312 - $2,932	400 Added 13.79%	3,300 $20,000
Q4 2023 Feb 14, 2024	SELL	$3.6 - $7.15 $41,040 - $81,510	-11,400 Reduced 79.72%	2,900 $20,000
Q3 2023 Nov 14, 2023	BUY	$4.79 - $7.19 $24,908 - $37,388	5,200 Added 57.14%	14,300 $70,000
Q2 2023 Aug 14, 2023	SELL	$5.19 - $8.07 $86,673 - $134,769	-16,700 Reduced 64.73%	9,100 $61,000
Q1 2023 May 15, 2023	SELL	$5.04 - $8.6 $225,288 - $384,420	-44,700 Reduced 63.4%	25,800 $133,000
Q4 2022 Feb 14, 2023	BUY	$5.8 - $8.98 $216,340 - $334,954	37,300 Added 112.35%	70,500 $459,000
Q3 2022 Nov 14, 2022	BUY	$7.55 - $11.25 $135,145 - $201,375	17,900 Added 116.99%	33,200 $279,000

100

45.4M

19.2K

31K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $288M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.